Comparison |
Alternate Manufacturer Number |
2069276 | 3567708 | | 1794049 | 3760550 |
Container Type |
Bottle | Bottle | Single-Dose Kit | Bottle | Bottle |
Country of Origin |
Unknown | Unknown | Unknown | Ireland | Ireland |
Dosage Form |
Tablet | Tablet | Injection | Tablet | Tablet |
Generic Drug Code |
35079 | | | 98986 | 44426 |
Generic Drug Name |
Dolutegravir Sodium | Dolutegravir Sodium | Cabotegravir | Raltegravir Potassium | Bictegravir Sodium / Emtricitabine / Tenofovir Alafenamide Fumarate |
NDC Number |
49702022813 | 49702022613 | 49702026423 | 00006022761 | 61958250101 |
Quantity |
30 Tablets | 30 Tablets | | 60 Tablets | 30 Tablets |
Storage Requirements |
| | Requires Refrigeration | | |
Strength |
50 mg | 10 mg | 600 mg / mL | 400 mg | 50 mg - 200 mg - 25 mg |
Type |
| | Intramuscular | | |
UNSPSC Code |
51343204 | 51343204 | 51343700 | 51343201 | 51343800 |
Volume |
| | 3 mL | | |
Application |
HIV Integrase Inhibitor | HIV Integrase Inhibitor | HIV Integrase Inhibitor | HIV Integrase Inhibitor | HIV Integrase Inhibitor |
Product Dating |
McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days |
Features and Benefits |
- TIVICAY is a prescription medicine that is used together with other antiretroviral medicines to treat Human Immunodeficiency Virus (HIV‑1) infection in adults and children who weigh at least 66 pounds
- Film Coated
|
|
- Cabotegravir extended-release injectable suspension
- For gluteal intramuscular use only
- Indicated in at-risk adults and adolescents weighing at least 35 kg for PrEP to reduce the risk of sexually acquired HIV-1 infection
- Contents: 1 Single-dose vial, 1 Vial Adapter, 1 Syringe, 1 Injection needle (23 gauge, 1-1/2 Inch)
|
|
|